Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound brings more weight loss than Wegovy
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly.
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
43m
on MSN
Elon Musk contributed more than $250 million to 2024 campaign groups backing Donald Trump
The world's richest person, Elon Musk contributed more than a quarter-billion dollars to 2024 campaign committees that helped Trump win a second term.
9h
on MSN
Musk spent more than a quarter-billion dollars to elect Trump, including funding a mysterious super PAC, new filings show
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
US adds 227,000 jobs
Tsunami warnings lifted
'Patriot of the Year' award
White Sox legend dies
Biden considers pardons
Several prisons to be closed
Promotes trade w/ Mexico
Today in history: 1964
To be ambassador to China
Pledges hit $100 billion
Winter storm to hit US
Meet with lawmakers
Wild bird lays egg at 74
Moon missions delayed
Scott tapped to lead CBP
Sacks to lead AI, crypto
Images of suspect released
Blackhawks fire coach
NBA returning to China
Joins X Games as CEO
Judge rejects plea deal
Set to return after 20 years
Ethics report release blocked
Delays oil output hike
Jury deliberations continue
New AI tools for employees
Airbus layoffs
Prenatal test spots cancer?
Airlines to pay for delays?
Satellites to create eclipses
2024 U.S. Elections
The latest news on national races.
See more
Feedback